ARCHIVES

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

Too Few Minority Scientists Enter Careers In Public Health, Oncology, Bynum Reports

March 24, 1989

Rejecting Data, Believers In PSA Screening Strengthen Guidelines, Launch Outreach

September 11, 2009